How Howard White got a second heart

September 28, 2023 Providence Marketing

one hand giving a fake heart to another hand

[2 MIN READ | 3 MIN WATCH]

Across seven states, Providence sees many inspirational patient stories every day. Behind every patient story, there’s a “why” our caregivers seek to uncover. This “why” is what motivates our clinical and surgical experts to show up every day. Our unwavering effort to see the life in every patient is why patients continually turn to Providence for care.

When famed basketball maven Howard White learned his heart was failing, he turned to the dream team at Providence to keep his legacy alive. Led by Dr. Jacob Abraham, Medical Director of Providence Heart Institute’s Center for Advanced Heart Disease in Portland, Oregon, Mr. White’s clinical team knew he was a likely candidate for a heart transplant.

“From the medical perspective, he was clearly in congestive heart failure, which led us to pursue investigation for a heart transplant,” said Dr. Abraham.

From congestive heart failure to new heart

“I remember plain as day when they walked in my hospital room and said ‘you might need a new heart,’” said Mr. White. Unfazed and always the optimist, Mr. White simply asked about the next steps. “When I think about how the best teams work, it is a collaborative effort; when I came into get my heart transplant, I just saw these doctors…they were a team.”

Watch Mr. White's story of perseverance below.

Mr. White inspired us, and we hope you will find inspiration in his story, too.

Note: This video was produced in partnership with Courageous Studios, a brand studio for CNN.

Experience more stories from Providence by visiting our blog.

Find a doctor

Find a Providence doctor in your area by searching in our provider directory.

Providence in your inbox

Subscribe to our newsletter to get more educational and inspirational stories from the expert caregivers at Providence.

Related Resources

AFib awareness: Learn about risks, treatments and the latest research

Men’s heart health: Prevention and wellness strategies

The future of cardiovascular care: A conversation with Matt Ducsik

Rehabilitation after a stroke is vital to recovery

About the Author

Kelby has spent the last five years leading the content strategy, editorial programming, and brand storytelling for Providence. He's a connector with a passion is finding the cultural and expert insights that can be turned into relevant and helpful stories that help people live happy and healthy lives.
More Content by Providence Marketing

Welcome to your journey for creating a healthier you

How Howard White got a second heart

In this article:

The Providence Heart Institute gave Howard White, basketball expert and advisor to Michael Jordan, a second chance.

Congestive heart failure has many treatment options, including transplant.

From congestive heart failure to new heart

Find a doctor

Providence in your inbox

Related Resources

About the Author

Previous Article

Next Article

How Howard White got a second heart

In this article:

The Providence Heart Institute gave Howard White, basketball expert and advisor to Michael Jordan, a second chance.

Congestive heart failure has many treatment options, including transplant.

From congestive heart failure to new heart

Find a doctor

Providence in your inbox

Related Resources

About the Author

Previous Article

Next Article

Other content in this Stream

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

Free educational presentations from Providence Senior Health are taking place in September in Beaverton, Hillsboro, Seaside and Medford. See the schedule and registration information.

Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

Hospice volunteers offer respite to family members, care for patients at the end of their lives and help people navigate grief. Learn about their service and how to volunteer.

“For my patients.” “For my friend’s daughter.” “For the challenge.” “For the cure.” Providence runners and walkers share why they’re doing the relay – and helping raise funds to #FINISHCANCER.

Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Cancer survivor Mark Williams chats with Dr. Brendan Curti about

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

In 2023, Providence in Oregon did so much to make sure that essential resources – such as health care, food and shelter – were more readily available to the people of our state.

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec